{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:03:20Z","timestamp":1779775400742,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.7759\/cureus.109650","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:17:36Z","timestamp":1779772656000},"source":"Crossref","is-referenced-by-count":0,"title":["Don\u2019t Miss the Blind Spots: Incidental Detection of Choroidal Melanoma During Primary Care Evaluation of Visual Field Loss"],"prefix":"10.7759","author":[{"given":"Omar J","family":"Bishr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adityanarayan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saji","family":"Packal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973-1997","volume":"110","author":"Singh AD","year":"2003","unstructured":"Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003, 110:956-61. 10.1016\/S0161-6420(03)00078-2","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5190","article-title":"Current molecular and clinical insights into uveal melanoma (review)","volume":"58","author":"Fallico M","year":"2021","unstructured":"Fallico M, Raciti G, Longo A, et al.. Current molecular and clinical insights into uveal melanoma (review). Int J Oncol. 2021, 58:10.3892\/ijo.2021.5190","journal-title":"Int J Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.5140","article-title":"Update on uveal melanoma: translational research from biology to clinical practice (review)","volume":"57","author":"Ortega MA","year":"2020","unstructured":"Ortega MA, Fraile-Mart\u00ednez O, Garc\u00eda-Honduvilla N, Coca S, \u00c1lvarez-Mon M, Buj\u00e1n J, Teus MA. Update on uveal melanoma: translational research from biology to clinical practice (review). Int J Oncol. 2020, 57:1262-79. 10.3892\/ijo.2020.5140","journal-title":"Int J Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0622-9","article-title":"Uveal melanoma-associated survival in Scotland","volume":"33","author":"Jamison A","year":"2019","unstructured":"Jamison A, Bhatti LA, Sobti MM, Chadha V, Cauchi P, Kemp EG. Uveal melanoma-associated survival in Scotland. Eye (Lond). 2019, 33:1699-706. 10.1038\/s41433-019-0622-9","journal-title":"Eye (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2023-324687","article-title":"Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma","volume":"109","author":"Gallo B","year":"2024","unstructured":"Gallo B, Hussain R, Al-Jamal R, et al.. Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma. Br J Ophthalmol. 2024, 109:76-82. 10.1136\/bjo-2023-324687","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000519","article-title":"20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas","volume":"30","author":"Bellocq D","year":"2020","unstructured":"Bellocq D, Roy P, Kodjikian L, et al.. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas. Melanoma Res. 2020, 30:272-8. 10.1097\/CMR.0000000000000519","journal-title":"Melanoma Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2025.2480188","article-title":"The small choroidal melanoma: diagnosis, treatment outcomes, and unending controversy","volume":"40","author":"Mishra K","year":"2025","unstructured":"Mishra K, Mruthyunjaya P. The small choroidal melanoma: diagnosis, treatment outcomes, and unending controversy. Semin Ophthalmol. 2025, 40:624-33. 10.1080\/08820538.2025.2480188","journal-title":"Semin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03851-9","article-title":"Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma","volume":"148","author":"Sabazade S","year":"2022","unstructured":"Sabazade S, Gill V, Herrspiegel C, St\u00e5lhammar G. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma. J Cancer Res Clin Oncol. 2022, 148:587-97. 10.1007\/s00432-021-03851-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref9","article-title":"Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance","volume":"42","author":"Kivel\u00e4 T","year":"2001","unstructured":"Kivel\u00e4 T, Eskelin S, M\u00e4kitie T, Summanen P. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001, 42:2085-93.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02782-8","article-title":"Multimodal imaging risk factors predictive of small choroidal melanocytic lesion growth to melanoma: an educational study and pictorial guide","volume":"38","author":"Churchill RA","year":"2024","unstructured":"Churchill RA, Pecoraro TY, Tooley AA, Houghton OM, Mashayekhi A, Dalvin LA. Multimodal imaging risk factors predictive of small choroidal melanocytic lesion growth to melanoma: an educational study and pictorial guide. Eye (Lond). 2024, 38:798-805. 10.1038\/s41433-023-02782-8","journal-title":"Eye (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002440","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin lecture","volume":"39","author":"Shields CL","year":"2019","unstructured":"Shields CL, Dalvin LA, Ancona-Lezama D, et al.. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin lecture. Retina. 2019, 39:1840-51. 10.1097\/IAE.0000000000002440","journal-title":"Retina"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702779","article-title":"Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases","volume":"22","author":"Petrausch U","year":"2008","unstructured":"Petrausch U, Martus P, T\u00f6nnies H, et al.. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye (Lond). 2008, 22:997-1007. 10.1038\/sj.eye.6702779","journal-title":"Eye (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00447","article-title":"15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of Collaborative Ocular Oncology Group Study No. 2 (Coog2.1)","volume":"42","author":"Harbour JW","year":"2024","unstructured":"Harbour JW, Correa ZM, Schefler AC, et al.. 15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of Collaborative Ocular Oncology Group Study No. 2 (Coog2.1). J Clin Oncol. 2024, 42:3319-29. 10.1200\/JCO.24.00447","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14214","article-title":"Current management of uveal melanoma: a review","volume":"51","author":"Bai H","year":"2023","unstructured":"Bai H, Bosch JJ, Heindl LM. Current management of uveal melanoma: a review. Clin Exp Ophthalmol. 2023, 51:484-94. 10.1111\/ceo.14214","journal-title":"Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","author":"Gallie B","year":"2016","unstructured":"Gallie B, Simpson E, Saakyan S, et al.. Local recurrence significantly increases the risk of metastatic uveal melanoma. Ophthalmology. 2016, 123:86-91. 10.1016\/j.ophtha.2015.09.014","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471804-dont-miss-the-blind-spots-incidental-detection-of-choroidal-melanoma-during-primary-care-evaluation-of-visual-field-loss","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:17:37Z","timestamp":1779772657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471804-dont-miss-the-blind-spots-incidental-detection-of-choroidal-melanoma-during-primary-care-evaluation-of-visual-field-loss"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109650","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}